There is no cure for migraines. Migraine is a chronic neurological condition, and no treatment currently available can eliminate it permanently. But the gap between “no cure” and “no help” is enormous. Modern treatments can cut monthly migraine days in half or more for many people, and a combination of medication, lifestyle changes, and newer therapies can make the condition far more manageable than it was even a decade ago.
About 14% of the global population experiences migraines each year, making it the second leading contributor to neurological disability worldwide. The number of people affected rose from roughly 733 million in 1990 to 1.16 billion in 2021. Understanding what’s available now, and what’s realistic to expect, matters.
Why Migraines Can’t Be Cured Yet
Migraine isn’t a single problem with a single fix. It involves a complex chain of events in the brain: overactive nerve signaling, inflammation around blood vessels, and shifts in brain chemistry that researchers are still mapping. Because the condition is rooted in how your nervous system is wired and how it responds to triggers, there’s no surgery or drug that can switch it off at the source.
One of the most promising newer drug classes, which works by blocking a pain-signaling protein called CGRP, illustrates this perfectly. These medications can produce dramatic improvements while you’re taking them. But studies show that headache frequency and quality of life tend to worsen after stopping, and the brain changes they produce don’t appear to be maintained long-term. The improvements depend on continued treatment, not a permanent biological reset. That said, “not a cure” doesn’t mean “not life-changing.” For many people, staying on an effective preventive medication transforms their daily experience.
Preventive Medications That Reduce Attacks
Preventive treatment aims to reduce how often migraines happen and how severe they are. The newer CGRP-blocking antibodies, given as monthly or quarterly injections, are among the most effective options. In a 12-month Australian study, 80% of patients who continued treatment achieved at least a 50% reduction in monthly headache days. The median reduction was 18 fewer headache days per month compared to baseline. Even in the first three months, over half of patients hit that 50% threshold.
Older preventive options still play a role. Topiramate, an anti-seizure medication, and Botox injections (approved specifically for chronic migraine, defined as 15 or more headache days per month for at least three months) remain standard choices. But adherence is a well-known problem with preventive medications. Side effects, cost, and the need for consistent use all contribute to people stopping treatment early, which is one reason migraines remain undertreated despite available options.
Treating Attacks When They Happen
Acute treatments aim to stop or reduce a migraine once it starts. Triptans have been the go-to for decades and remain effective for many people. A newer class called gepants works through a different mechanism (also targeting CGRP signaling) and offers a comparable rate of pain freedom at two hours. In real-world data from a large U.S. cohort, triptans and gepants showed similar effectiveness for short-term pain relief, though gepants had an edge in sustained relief over 24 hours.
The choice between these often comes down to side effects and individual response. Triptans constrict blood vessels, which makes them unsuitable for people with certain cardiovascular conditions. Gepants avoid that issue. Some people respond well to one class and not the other, so finding the right acute treatment can take trial and error.
Devices That Stimulate Nerves
Neuromodulation devices offer a drug-free option for both preventing and treating migraine attacks. These are wearable or handheld devices cleared by the FDA that deliver electrical or magnetic pulses to specific nerves.
- External trigeminal nerve stimulation (Cefaly device): Worn on the forehead, it stimulates the trigeminal nerve. For prevention, 38% of users saw at least a 50% reduction in migraine days, compared to 12% with a placebo device. For acute use, it reduced pain by 59% after 60 minutes of treatment, roughly double the placebo effect.
- Single-pulse transcranial magnetic stimulation: A handheld device held against the back of the head. For acute treatment, 39% of users were pain-free at two hours versus 22% with sham stimulation. As a preventive, it reduced headache days by an average of 2.75 per month.
These devices won’t replace medication for everyone, but they’re useful for people who can’t tolerate drugs, want to reduce their medication load, or need an additional layer of treatment.
How Lifestyle Changes Fit In
Lifestyle modifications sound less exciting than new drugs, but the data behind them is surprisingly strong. A Cleveland Clinic analysis found that the number needed to treat with routine lifestyle changes (consistent sleep, diet, and exercise habits) is just 2. That means every other person who commits to these changes sees meaningful benefit.
Sleep stands out as particularly powerful. Behavioral modification for sleep hygiene, meaning consistent bed and wake times, a dark and cool room, and limiting screens before bed, can convert chronic migraine to episodic migraine on its own. That’s a shift from 15-plus headache days per month to fewer than 15, which represents a major quality-of-life improvement.
Exercise helps modestly on its own, reducing monthly migraine days by about 0.6 days on average, with greater benefits at higher intensities. Cognitive behavioral therapy has been shown to decrease migraine disability, headache severity, and frequency. Mindfulness-based approaches improve pain intensity, headache frequency, and overall quality of life. None of these is a cure, but stacking them together with medical treatment often produces the best results.
Supplements: Limited but Possible Benefit
Riboflavin (vitamin B2) and magnesium are the most commonly discussed supplements for migraine prevention. In a randomized controlled trial, even a low dose of riboflavin (25 mg daily) produced a 44% rate of cutting migraines by half or more. A higher-dose combination of riboflavin 400 mg, magnesium 300 mg, and feverfew 100 mg performed almost identically at 42%, suggesting that riboflavin may be doing most of the work and that more isn’t necessarily better. The evidence is real but modest, and supplements alone are unlikely to be sufficient for frequent migraines.
What Realistic Improvement Looks Like
Since a cure isn’t available, the practical goal is reducing how many days per month migraine controls your life. For someone with chronic migraine, a realistic good outcome with modern treatment might look like cutting headache days from 20 per month to 5 or fewer. Some people on CGRP-blocking medications achieve near-complete suppression of attacks while on treatment. Others find that a combination of a preventive medication, a reliable acute treatment, and consistent lifestyle habits brings their migraine burden down to something manageable.
The trajectory matters too. Chronic migraine (15-plus days per month) can sometimes be reversed to episodic migraine through treatment and lifestyle changes, which reduces the overall disease burden even if individual attacks still occur. The earlier and more consistently you treat, the less likely the condition is to worsen over time.
Research into new drug targets is active. Combination therapies blocking multiple pain-signaling pathways at once are in development, and early clinical trials targeting a protein called PACAP alongside CGRP have shown promise. Whether any of this eventually leads to something closer to a cure remains an open question, but the tools available right now are more effective than anything that existed 10 years ago.